BD-1047

BD-1047 is a sigma receptor antagonist, selective for the σ₁ subtype. It has effects in animal studies suggestive of antipsychotic activity and may also be useful in the treatment of neuropathic pain.^[1][2]

BD-1047

Clinical data
ATC code	none
Identifiers
IUPAC name N'-[2-(3,4-dichlorophenyl)ethyl]-N,N,N'-trimethylethane-1,2-diamine
CAS Number	138356-20-4 N
PubChem CID	188914
IUPHAR/BPS	6680
ChemSpider	164154 Y
UNII	1S3X75QGDO
ChEMBL	ChEMBL143360 Y
CompTox Dashboard (EPA)	DTXSID70160640
Chemical and physical data
Formula	C13H20Cl2N2
Molar mass	275.22 g·mol−1
3D model (JSmol)	Interactive image
SMILES Clc1ccc(CCN(C)CCN(C)C)cc1Cl
InChI InChI=1S/C13H20Cl2N2/c1-16(2)8-9-17(3)7-6-11-4-5-12(14)13(15)10-11/h4-5,10H,6-9H2,1-3H3 Y Key:MGVRNMUKTZOQOW-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

More recent studies also suggest a novel role for BD-1047 in attenuating ethanol-induced neurotoxicity in vitro, and additional research is being conducted on this compound as a possible pharmacotherapy for alcohol use disorder (AUD) ^[3]